Randomized controlled trial of 60-Minutes-for-Health with rapid antiretroviral therapy to re-engage persons with HIV who are out of care

IF 2.9 3区 医学 Q3 IMMUNOLOGY JAIDS Journal of Acquired Immune Deficiency Syndromes Pub Date : 2024-05-16 DOI:10.1097/qai.0000000000003460
Thomas CS Martin T, Laramie R Smith, Christy Anderson, Susan J Little
{"title":"Randomized controlled trial of 60-Minutes-for-Health with rapid antiretroviral therapy to re-engage persons with HIV who are out of care","authors":"Thomas CS Martin T, Laramie R Smith, Christy Anderson, Susan J Little","doi":"10.1097/qai.0000000000003460","DOIUrl":null,"url":null,"abstract":"\n \n Many persons with HIV remain out of care (PWH-OOC). We evaluated InstaCare, a complex intervention integrating the brief behavioral intervention 60-Minutes-for-Health with rapid re-start of antiretroviral therapy (rapid-ART).\n \n \n \n Prospective open-label randomized controlled trial among PWH-OOC in San Diego, USA\n \n \n \n PWH-OOC were randomized 1:1 to InstaCare or a time-and-attention control integrating a diet-and-nutrition behavioral intervention also with rapid-ART initiation (restart ≤7 days from enrolment). All participants had access to support services (free transport, HIV peer-navigation, adherence counseling and linkage to care) and primary care services (mental health, case management, social work, medication assisted treatment, and specialist pharmacy). The primary outcomes were viral suppression (<50 copies/ml) and re-engagement with care (≥2 HIV care visits >90 days apart) by 24 weeks. Outcomes were reported on an intention-to-treat basis.\n \n \n \n Between November 2020 and August 2022, 52 PWH-OOC were enrolled. Baseline substance use in the preceding month (49%), unstable housing (51%), moderate/severe depression (49%), and moderate/severe anxiety (41.7%) were prevalent. Rapid-ART was provided for all participants. At week 24, the proportion with HIV viral load <50 copies/ml was 37.3% (19/51) (InstaCare 28.0%, control 46.2%, p=0.25). Fourteen (27.5%) were engaged with care (InstaCare 7/25 [28.0%], control 7/26 [26.9%], p=1.00). Most participants (94%) reported low or very low emotional distress associated with rapid-ART. Study lost to follow-up by week 24 was high (23/51, 45%).\n \n \n \n The InstaCare complex intervention did not improve viral suppression or re-engagement with care among PWH-OOC. Investigation of high-intensity, individually-adapted interventions are needed among PWH-OOC.\n","PeriodicalId":14588,"journal":{"name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","volume":null,"pages":null},"PeriodicalIF":2.9000,"publicationDate":"2024-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAIDS Journal of Acquired Immune Deficiency Syndromes","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/qai.0000000000003460","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Many persons with HIV remain out of care (PWH-OOC). We evaluated InstaCare, a complex intervention integrating the brief behavioral intervention 60-Minutes-for-Health with rapid re-start of antiretroviral therapy (rapid-ART). Prospective open-label randomized controlled trial among PWH-OOC in San Diego, USA PWH-OOC were randomized 1:1 to InstaCare or a time-and-attention control integrating a diet-and-nutrition behavioral intervention also with rapid-ART initiation (restart ≤7 days from enrolment). All participants had access to support services (free transport, HIV peer-navigation, adherence counseling and linkage to care) and primary care services (mental health, case management, social work, medication assisted treatment, and specialist pharmacy). The primary outcomes were viral suppression (<50 copies/ml) and re-engagement with care (≥2 HIV care visits >90 days apart) by 24 weeks. Outcomes were reported on an intention-to-treat basis. Between November 2020 and August 2022, 52 PWH-OOC were enrolled. Baseline substance use in the preceding month (49%), unstable housing (51%), moderate/severe depression (49%), and moderate/severe anxiety (41.7%) were prevalent. Rapid-ART was provided for all participants. At week 24, the proportion with HIV viral load <50 copies/ml was 37.3% (19/51) (InstaCare 28.0%, control 46.2%, p=0.25). Fourteen (27.5%) were engaged with care (InstaCare 7/25 [28.0%], control 7/26 [26.9%], p=1.00). Most participants (94%) reported low or very low emotional distress associated with rapid-ART. Study lost to follow-up by week 24 was high (23/51, 45%). The InstaCare complex intervention did not improve viral suppression or re-engagement with care among PWH-OOC. Investigation of high-intensity, individually-adapted interventions are needed among PWH-OOC.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
采用快速抗逆转录病毒疗法的 "60 分钟促进健康 "随机对照试验,帮助脱离护理的艾滋病毒感染者重新融入社会
许多艾滋病病毒感染者(PWH-OOC)仍然得不到护理。我们对InstaCare进行了评估,这是一种将简短行为干预 "60分钟促进健康 "与快速重新启动抗逆转录病毒疗法(快速抗逆转录病毒疗法)相结合的综合干预措施。 在美国圣迭戈的艾滋病病毒感染者(PWH-OOC)中进行的前瞻性开放标签随机对照试验将艾滋病病毒感染者(PWH-OOC)以 1:1 的比例随机分配到 InstaCare 或一个时间-注意力对照组,后者也结合了饮食-营养行为干预和快速ART 启动(自注册起 7 天内重新启动)。所有参与者均可获得支持服务(免费交通、艾滋病同伴导航、坚持咨询和护理链接)和初级护理服务(心理健康、个案管理、社会工作、药物辅助治疗和专科药房)。主要结果是在 24 周内病毒得到抑制(间隔 90 天)。结果以意向治疗为基础进行报告。 2020 年 11 月至 2022 年 8 月期间,52 名 PWH-OOC 参与了研究。他们普遍在前一个月使用过药物(49%)、住房不稳定(51%)、中度/重度抑郁(49%)和中度/重度焦虑(41.7%)。所有参与者都接受了快速抗逆转录病毒治疗。第 24 周时,HIV 病毒载量小于 50 copies/ml 的比例为 37.3%(19/51)(InstaCare 28.0%,对照 46.2%,P=0.25)。14人(27.5%)接受了护理(InstaCare 7/25 [28.0%],对照组 7/26 [26.9%],P=1.00)。大多数参与者(94%)表示,与快速抗逆转录病毒疗法相关的情绪困扰程度较低或非常低。研究到第 24 周时失去随访的人数较多(23/51,45%)。 InstaCare综合干预并未改善PWH-OOC的病毒抑制或重新参与治疗的情况。有必要对 PWH-OOC 进行高强度、适合个人情况的干预调查。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
5.80
自引率
5.60%
发文量
490
审稿时长
3-6 weeks
期刊介绍: JAIDS: Journal of Acquired Immune Deficiency Syndromes​ seeks to end the HIV epidemic by presenting important new science across all disciplines that advance our understanding of the biology, treatment and prevention of HIV infection worldwide. JAIDS: Journal of Acquired Immune Deficiency Syndromes is the trusted, interdisciplinary resource for HIV- and AIDS-related information with a strong focus on basic and translational science, clinical science, and epidemiology and prevention. Co-edited by the foremost leaders in clinical virology, molecular biology, and epidemiology, JAIDS publishes vital information on the advances in diagnosis and treatment of HIV infections, as well as the latest research in the development of therapeutics and vaccine approaches. This ground-breaking journal brings together rigorously peer-reviewed articles, reviews of current research, results of clinical trials, and epidemiologic reports from around the world.
期刊最新文献
Predictors of Injection Visit Adherence in Those Receiving Injectable Cabotegravir/Rilpivirine. Real-world comparative Analysis of Liposomal Doxorubicin versus Paclitaxel as First-Line Therapy for Kaposi Sarcoma. Immune Activation Is Associated With Neurocognitive Performance in Ugandan Adolescents Living With HIV. Beyond Viral Suppression-The Impact of Cumulative Violence on Health-Related Quality of Life Among a Cohort of Virally Suppressed Patients: Erratum. Brief Report: Alternative Pulmonary Function Measures of Emphysema in People With HIV.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1